Literature DB >> 8205010

Biochemistry of factor X.

M Hertzberg1.   

Abstract

Factor X circulates as a serine protease which is converted to the active form at the point of convergence of the intrinsic and extrinsic coagulation pathways. Subsequently, the enzymatic species, factor Xa, is involved in macromolecular complex formation with its cofactor factor Va, a phospholipid surface and calcium to convert prothrombin into thrombin. The gene encoding factor X shares a number of structural and organisational features in common with the other vitamin K-dependent coagulation proteins, suggesting that they have evolved from a common ancestral gene. Each of the exons encoding these proteins can be considered as a module coding for a homologous domain in each protein. These structural domains in factor X are responsible for specific functional properties including gamma-carboxylase recognition, calcium binding, phospholipid surface interaction, as well as cofactor and substrate binding. Studies of recombinant proteins and proteolytic fragments continue to provide significant insight into structure-function relationships of the protein modules within factor X.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8205010     DOI: 10.1016/0268-960x(94)90007-8

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  7 in total

1.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

2.  Mass spectrometry based analysis of human plasma-derived factor X revealed novel post-translational modifications.

Authors:  Guillaume Chevreux; Nolwenn Tilly; Valegh Faid; Nicolas Bihoreau
Journal:  Protein Sci       Date:  2015-09-18       Impact factor: 6.725

3.  Factor Xa active site substrate specificity with substrate phage display and computational molecular modeling.

Authors:  Hung-Ju Hsu; Keng-Chang Tsai; Yi-Kun Sun; Hung-Ju Chang; Yi-Jen Huang; Hui-Ming Yu; Chun-Hung Lin; Shi-Shan Mao; An-Suei Yang
Journal:  J Biol Chem       Date:  2008-02-22       Impact factor: 5.157

4.  Rapid purification of high purity thrombin and preparation of a novel hemostat for clinical purposes.

Authors:  Krishna Kumar Turaga; P Chakradhara Rao; G Sripad
Journal:  Indian J Hematol Blood Transfus       Date:  2008-08-24       Impact factor: 0.900

5.  Membranoproliferative glomerulonephritis and a rare bleeding disorder: Factor X deficiency.

Authors:  T Basturk; E Ahbap; B Eroglu Kesim; M Yılmaz; Y Koç; T Sakacı; A Unsal
Journal:  Int Urol Nephrol       Date:  2010-09-23       Impact factor: 2.370

Review 6.  Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics.

Authors:  Rodney M Camire
Journal:  J Thromb Thrombolysis       Date:  2021-04-22       Impact factor: 5.221

7.  Coagulation factor X interaction with macrophages through its N-glycans protects it from a rapid clearance.

Authors:  Mohamad Kurdi; Ghislaine Cherel; Peter J Lenting; Cécile V Denis; Olivier D Christophe
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.